Jutley et al. discuss established glaucoma treatments, review promising new neuroprotective agents, and explore potential future treatments targeting the neurodenegerative processes in glaucoma.
Browsing: Journal Articles
In this perspective article, the authors draw attention toward the pharmacoepigenomic influence of antipsychotic drugs, and distinguish its significance from therapeutic response and schizophrenia pathogenesis.
In this research article, auditory comprehension and visually assessed cognitive functions were compared in early stage postconcussed athletes and healthy controls using the Subtest VIII of the Computerized-Revised Token Test and Immediate Postconcussion Assessment and Cognitive Test.
Amyloid positron emission tomography (aPET) measurement of Alzheimer’s disease (AD) pathology could improve the accurate diagnosis of cognitive disorders.
A short opinion piece updating “Lost in translation: understanding the failure of the progesterone/traumatic brain injury Phase III trials”.
A scientific communication that attempts to understand the attitudes of Chinese medical students toward clinical neuroscience to provide a necessary step in curriculum development and reform in the neurosciences.
This article focuses the choice of surgical treatment in an unoperated patient with clinically established trigeminal neuralgia.
Insight into the current research areas utilizing stem cell models to provide new evidence of the pathobiology of schizopheria and bipolar disorder, followed by how this can influence the development of new targeted therapies.
This article evaluates the potential role of vascular dysfunction and chronic inflammation in both acute- and chronic-phase traumatic brain injury, and also features studies investigating biomarkers associated with poorer injury outcome.
An evaluation of ‘IL4I1 augments CNS remyelination and axonal protection by modulating T-cell driven inflammation’, recently published in Brain.